David W. Craig, Ph.D., is an internationally recognized leader in developing and applying novel bioinformatics and genomics tools, as well as translating genomic discoveries from bench to bedside.
Dr. Craig leads the Department of Integrative Translational Sciences, which focuses on precision measurement, data science and diversity. It will seek to further improve both translational outcomes, as well as the science underpinning the use of precision medicine.
Dr. Craig leads the establishment of a transdisciplinary team of biologists and data scientists who will work with engineers, chemists and clinicians across the system to enhance City of Hope’s patient-centered mission. He also will collaborate with regulatory agencies, industry partners, researchers and health care professionals to integrate scientific findings and translate potentially practice-changing discoveries into improved patient care and human health.
He has spearheaded collaborative computational and data science efforts within large and small research consortiums, including the 1000 Genomes Project and the Bipolar Genome Study. His exceptional expertise has resulted in more than 200 publications, four patents and two founded companies.
Dr. Craig earned his Ph.D. from the University of Washington, focusing on bioengineering. Dr. Craig joins City of Hope from the University of Southern California, where he was co-director of the Institute of Translational Genomics and vice chair of the Department of Translational Genomics at Keck School of Medicine of USC. He served as the director of the USC Norris Comprehensive Cancer Center Molecular Genomics Core and created their Translational Biomedical Informatics master’s degree program. Before USC, Dr. Craig served as the deputy director of Bioinformatics at Translational Genomics Research Institute and as director of the Neurogenomics division.
